Purpose: We developed an artificial neural network (ANN) combining radiomics with clinical and dosimetric features to predict the extent of body mass index (BMI) increase after surgery and proton therapy, with advantage of improved accuracy and integrated key feature selection. Methods and Materials: Uniform treatment protocol composing of limited surgery and proton radiotherapy was given to 84 pediatric craniopharyngioma patients (aged 1-20 years). Post-treatment obesity was classified into 3 groups (<10%, 10-20%, and >20%) based on the normalized BMI increase during a 5-year follow-up. We developed a densely connected 4-layer ANN with radiomics calculated from pre-surgery MRI (T1w, T2w, and FLAIR), combining clinical and dosimetric features as input. Accuracy, area under operative curve (AUC), and confusion matrices were compared with random forest (RF) models in a 5-fold cross-validation. The Group lasso regularization optimized a sparse connection to input neurons to identify key features from high-dimensional input. Results: Classification accuracy of the ANN reached above 0.9 for T1w, T2w, and FLAIR MRI. Confusion matrices showed high true positive rates of above 0.9 while the false positive rates were below 0.2. Approximately 10 key features selected for T1w, T2w, and FLAIR MRI, respectively. The ANN improved classification accuracy by 10% or 5% when compared to RF models without or with radiomic features. Conclusion: The ANN model improved classification accuracy on post-treatment obesity compared to conventional statistics models. The clinical features selected by Group lasso regularization confirmed our practical observation, while the additional radiomic and dosimetric features could serve as imaging markers and mitigation methods on post-treatment obesity for pediatric craniopharyngioma patients.

Purpose: Convolutional neural networks (CNNs) are promising in predicting treatment outcome for pediatric craniopharyngioma while the decision mechanisms are difficult to interpret. We compared the activation maps of CNN with hand crafted radiomics features of a densely connected artificial neural network (ANN) to correlate with clinical decisions. Methods: A cohort of 100 pediatric craniopharyngioma patients were included. Binary tumor progression was classified by an ANN and CNN with input of T1w, T2w, and FLAIR MRI. Hand-crafted radiomic features were calculated from the MRI using the LifeX software and key features were selected by Group lasso regularization, comparing to the activation maps of CNN. We evaluated the radiomics models by accuracy, area under receiver operational curve (AUC), and confusion matrices. Results: The average accuracy of T1w, T2w, and FLAIR MRI was 0.85, 0.92, and 0.86 (ANOVA, F = 1.96, P = 0.18) with ANN; 0.83, 0.81, and 0.70 (ANOVA, F = 10.11, P = 0.003) with CNN. The average AUC of ANN was 0.91, 0.97, and 0.90; 0.86, 0.88, and 0.75 of CNN for the 3 MRI, respectively. The activation maps were correlated with tumor shape, min and max intensity, and texture features. Conclusions: The tumor progression for pediatric patients with craniopharyngioma achieved promising accuracy with ANN and CNN model. The activation maps extracted from different levels were interpreted with hand-crafted key features of ANN.

Accurate and individualized human head models are becoming increasingly important for electromagnetic (EM) simulations. These simulations depend on precise anatomical representations to realistically model electric and magnetic field distributions, particularly when evaluating Specific Absorption Rate (SAR) within safety guidelines. State of the art simulations use the Virtual Population due to limited public resources and the impracticality of manually annotating patient data at scale. This paper introduces Personalized Head-based Automatic Simulation for EM properties (PHASE), an automated open-source toolbox that generates high-resolution, patient-specific head models for EM simulations using paired T1-weighted (T1w) magnetic resonance imaging (MRI) and computed tomography (CT) scans with 14 tissue labels. To evaluate the performance of PHASE models, we conduct semi-automated segmentation and EM simulations on 15 real human patients, serving as the gold standard reference. The PHASE model achieved comparable global SAR and localized SAR averaged over 10 grams of tissue (SAR-10 g), demonstrating its potential as a promising tool for generating large-scale human model datasets in the future. The code and models of PHASE toolbox have been made publicly available: https://github.com/hrlblab/PHASE.

This study aimed to validate the utility of commercially available vendor-neutral deep learning (DL) image enhancement software for improving the image quality of multiparametric MRI for gliomas in a multinational setting. A total of 294 patients from three institutions (NYU, Severance, and SNUH) who underwent glioma MRI protocols were included in this retrospective study. DL image enhancement was performed on T2-weighted (T2W), T2 FLAIR, and postcontrast T1-weighted (T1W) imaging using commercially available DL image enhancement software. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated for both conventional and DL-enhanced images. Three neuroradiologists, one from each institution, independently evaluated the following image quality parameters in both images using a 5-point scale: overall image quality, noise, gray-white matter differentiation, truncation artifact, motion artifact, pulsation artifact, and main lesion conspicuity. The quantitative and qualitative image parameters were compared between conventional and DL-enhanced images. Compared with conventional images, DL-enhanced images showed significantly higher SNRs and CNRs in T2W, T2 FLAIR, and postcontrast T1W imaging (all P < 0.001). The average scores of radiologist assessments in overall image quality, noise, gray-white matter differentiation, and main lesion conspicuity were significantly higher for DL-enhanced images than conventional images in T2W, T2 FLAIR, and postcontrast T1W imaging (all P < 0.001). Regarding artifacts, truncation artifacts decreased (all P < 0.001), while pre-existing motion and pulsation artifacts were not further exaggerated in most structural MRI sequences. In conclusion, DL image enhancement using commercially available vendor-neutral software improved image quality and reduced truncation artifacts in multiparametric glioma MRI.

We aim to conduct a systematic review and meta-analysis to objectively assess the diagnostic accuracy of artificial intelligence (AI) models for detecting ischemic stroke (IS) in non-contrast CT (NCCT), and to compare the diagnostic performance between AI and clinicians. Until February 2025, systematic searches were conducted in PubMed, Web of Science, Cochrane, IEEE Xplore, and Embase for studies using AI based on NCCT images from human subjects for IS detection or classification. The risk of bias was evaluated using the prediction model study risk of bias assessment tool (PROBAST). For meta-analysis, the pooled sensitivities, specificities, and hierarchical summary receiver operating characteristic (HSROC) curves were used. A total of 38 studies, with 74 trials extracted from 32 studies were included. For AI performance, the pooled sensitivity and specificity were 91.2% (95%CI: 87.6%-93.8%) and 96.0% (95%CI: 93.6%-97.6%) for internal validation and 59.8% (95%CI:39.9%-76.9%) and 97.3% (95%CI: 93.2%-98.9%) for external validation. For clinicians' performance, the pooled sensitivity and specificity were 44.1% (95%CI: 33.8%-55.0%) and 85.5% (95%CI: 68.4%-94.1%) for internal validation and 46.1% (95%CI: 31.5%-61.3%) and 83.6% (95%CI: 62.8%-93.9%) for external validation. The pooled sensitivity and specificity increased to 83.7% (95%CI: 53.0%-95.9%) and 86.7% (95%CI: 77.1%-92.6%) for clinicians with AI assistance. The subgroup analysis results indicated that higher model sensitivity was associated with the data augmentation (93.9%, 95%CI: 90.2%-96.2%) and transfer learning (94.7%, 95%CI: 92.0%-96.6%). There were 22 of 38 (58%) studies that were judged to have high risk of bias. Sensitive analysis and subgroup analysis identified multiple sources of heterogeneity in the data, including risk of bias and AI model types. Our study reveals that AI has an acceptable performance in detecting IS in NCCT in internal validation, although significant heterogeneity was observed in the meta-analysis. However, the generalizability and practical applicability of AI in real-world clinical settings remain limited due to insufficient external validation.

Brain metastases (BMs) are the most common intracranial tumors and stereotactic radiotherapy improved the life quality of patient with BMs, while it requires more time and experience to delineate BMs precisely by oncologists. Deep Learning techniques showed promising applications in radiation oncology. Therefore, we proposed a deep learning-based automatic segmentation of primary tumor volumes for BMs in this work. Magnetic resonance imaging (MRI) of 158 eligible patients with BMs was retrospectively collected in the study. An automatic segmentation model called BUC-Net based on U-Net with cascade strategy and bottleneck module was proposed for auto-segmentation of BMs. The proposed model was evaluated using geometric metrics (Dice similarity coefficient (DSC), 95% Hausdorff distance (HD95) and Average surface distance (ASD)) for the performance of automatic segmentation, and Precision recall (PR) and Receiver operating characteristic (ROC) curve for the performance of automatic detection, and relative volume difference (RVD) for evaluation. Compared with U-Net and U-Net Cascade, the BUC-Net achieved the average DSC of 0.912 and 0.797, HD95 of 0.901 mm and 0.922 mm, ASD of 0.332 mm and 0.210 mm for the evaluation of automatic segmentation in binary classification and multiple classification, respectively. The average Area Under Curve (AUC) of 0.934 and 0.835 for (Precision-Recall) PR and Receiver Operating Characteristic (ROC) curve for the tumor detection. It also performed the minimum RVD with various diameter ranges in the clinical evaluation. The BUC-Net can achieve the segmentation and modification of BMs for one patient within 10 min, instead of 3-6 h by the conventional manual modification, which is conspicuous to improve the efficiency and accuracy of radiation therapy.

Multiple sclerosis (MS) is a chronic neurological condition that affects approximately 150 000 people in the UK and presents a significant healthcare burden, including the high costs of disease-modifying treatments (DMTs). DMTs have substantially reduced the risk of relapse and moderately reduced disability progression. Patients exhibit a wide range of responses to available DMTs. The Predicting Optimal INdividualised Treatment response in MS (POINT-MS) cohort was established to predict the individual treatment response by integrating comprehensive clinical phenotyping with imaging, serum and genetic biomarkers of disease activity and progression. Here, we present the baseline characteristics of the cohort and provide an overview of the study design, laying the groundwork for future analyses. POINT-MS is a prospective, observational research cohort and biobank of 781 adult participants with a diagnosis of MS who consented to study enrolment on initiation of a DMT at the Queen Square MS Centre (National Hospital of Neurology and Neurosurgery, University College London Hospital NHS Trust, London) between 01/07/2019 and 31/07/2024. All patients were invited for clinical assessments, including the expanded disability status scale (EDSS) score, brief international cognitive assessment for MS and various patient-reported outcome measures (PROMs). They additionally underwent MRI at 3T, optical coherence tomography and blood tests (for genotyping and serum biomarkers quantification), at baseline (i.e., within 3 months from commencing a DMT), and between 6-12 (re-baseline), 18-24, 30-36, 42-48 and 54-60 months after DMT initiation. 748 participants provided baseline data. They were mostly female (68%) and White (75%) participants, with relapsing-remitting MS (94.3%), and with an average age of 40.8 (±10.9) years and a mean disease duration of 7.9 (±7.4) years since symptom onset. Despite low disability (median EDSS 2.0), cognitive impairment was observed in 40% of participants. Most patients (98.4%) had at least one comorbidity. At study entry, 59.2% were treatment naïve, and 83.2% initiated a high-efficacy DMT. Most patients (76.4%) were in either full- or part-time employment. PROMs indicated heterogeneous impairments in physical and mental health, with a greater psychological than physical impact and with low levels of fatigue. When baseline MRI scans were compared with previous scans (available in 668 (89%) patients; mean time since last scan 9±8 months), 26% and 8.5% of patients had at least one new brain or spinal cord lesion at study entry, respectively. Patients showed a median volume of brain lesions of 6.14 cm³, with significant variability among patients (CI 1.1 to 34.1). When brain tissue volumes z-scores were obtained using healthy subjects (N=113, (mean age 42.3 (± 11.8) years, 61.9% female)) from a local MRI database, patients showed a slight reduction in the volumes of the whole grey matter (-0.16 (-0.22 to -0.09)), driven by the deep grey matter (-0.47 (-0.55 to -0.40)), and of the whole white matter (-0.18 (-0.28 to -0.09)), but normal cortical grey matter volumes (0.10 (0.05 to 0.15)). The mean upper cervical spinal cord cross-sectional area (CSA), as measured from volumetric brain scans, was 62.3 (SD 7.5) mm². When CSA z-scores were obtained from the same healthy subjects used for brain measures, patients showed a slight reduction in CSA (-0.15 (-0.24 to -0.10)). Modelling with both standard statistics and machine learning approaches is currently planned to predict individualised treatment response by integrating all the demographic, socioeconomic, clinical data with imaging, genetic and serum biomarkers. The long-term output of this research is a stratification tool that will guide the selection of DMTs in clinical practice on the basis of the individual prognostic profile. We will complete long-term follow-up data in 4 years (January 2029). The biobank and MRI repository will be used for collaborative research on the mechanisms of disability in MS.

Radiotherapy (RT) of head and neck cancer can cause severe toxicities. Early identification of individuals at risk could enable personalized treatment. This study evaluated whether convolutional neural networks (CNNs) applied to Magnetic Resonance (MR) images acquired early after irradiation can predict radiation-induced tissue changes associated with toxicity in mice. Patient/material and methods: Twenty-nine C57BL/6JRj mice were included (irradiated: n = 14; control: n = 15). Irradiated mice received 65 Gy of fractionated RT to the oral cavity, swallowing muscles and salivary glands. T2-weighted MR images were acquired 3-5 days post-irradiation. CNN models (VGG, MobileNet, ResNet, EfficientNet) were trained to classify sagittal slices as irradiated or control (n = 586 slices). Predicted class probabilities were correlated with five toxicity endpoints assessed 8-105 days post-irradiation. Model explainability was assessed with VarGrad heatmaps, to verify that predictions relied on clinically relevant image regions. The best-performing model (EfficientNet B3) achieved 83% slice-level accuracy (ACC) and correctly classified 28 of 29 mice. Higher predicted probabilities of the irradiated class were strongly associated with oral mucositis, dermatitis, reduced saliva production, late submandibular gland fibrosis and atrophy of salivary gland acinar cells. Explainability heatmaps confirmed that CNNs focused on irradiated regions. The high CNN classification ACC, the regions highlighted by the explainability analysis and the strong correlations between model predictions and toxicity suggest that CNNs, together with post-irradiation magnetic resonance imaging, may identify individuals at risk of developing toxicity.

Punctate white matter lesions (PWML) are the most common white matter injuries found in preterm neonates, with several studies indicating a connection between these lesions and negative long-term outcomes. Automated detection of PWML through ultrasound (US) imaging could assist doctors in diagnosis more effectively and at a lower cost than MRI. However, this task is highly challenging because of the lesions' small size and low contrast, and the number of lesions can vary significantly between subjects. In this work, we propose a two-phase approach: (1) Segmentation using a vision transformer to increase the detection rate of lesions. (2) Multi-view classification leveraging cross-attention to reduce false positives and enhance precision. We also investigate multiple postprocessing approaches to ensure prediction quality and compare our results with what is known in MRI. Our method demonstrates improved performance in PWML detection on US images, achieving recall and precision rates of 0.84 and 0.70, respectively, representing an increase of 2% and 10% over the best published US models. Moreover, by reducing the task to a slightly simpler problem (detection of MRI-visible PWML), the model achieves 0.82 recall and 0.89 precision, which is equivalent to the latest method in MRI.

Neuroimaging studies of brain function are important research methods widely applied to stroke patients. Currently, a large number of studies have focused on functional imaging of the gray matter cortex. Relevant research indicates that certain areas of the gray matter cortex in stroke patients exhibit abnormal brain activity during resting state. However, studies on brain function based on white matter remain insufficient. The changes in functional connectivity caused by stroke in white matter, as well as the repair or compensation mechanisms of white matter function after stroke, are still unclear. The aim of this study is to investigate and demonstrate the changes in brain functional connectivity activity in the white matter region of stroke patients. Revealing the recombination characteristics of white matter functional networks after stroke, providing potential biomarkers for rehabilitation therapy Provide new clinical insights for the rehabilitation and treatment of stroke patients. We recruited 36 stroke patients and 36 healthy controls for resting-state functional magnetic resonance imaging (rs-fMRI). Regional Homogeneity (ReHo) and Degree Centrality (DC), which are sensitive to white matter functional abnormalities, were selected as feature vectors. ReHo reflects local neuronal synchrony, while DC quantifies global network hub properties. The combination of both effectively characterizes functional changes in white matter. ReHo evaluates the functional consistency of different white matter regions by calculating the activity similarity between adjacent brain regions. Additionally, DC analysis of white matter was used to investigate the connectivity patterns and organizational principles of functional networks between white matter regions. This was achieved by calculating the number of connections in each brain region to identify changes in neural activation of white matter regions that significantly impact the brain network. Furthermore, ReHo and DC metrics were used as feature vectors for classification using machine learning algorithms. The results indicated significant differences in white matter DC and ReHo values between stroke patients and healthy controls. In the two-sample t-test analysis of white matter DC, stroke patients showed a significant reduction in DC values in the corpus callosum genu (GCC), corpus callosum body (BCC), and left anterior corona radiata (ACRL) regions (GCC: 0.143 vs. 1.024; BCC: 0.238 vs. 1.143; ACRL: 0.143 vs. 0.821, p < 0.001). However, an increase in DC values was observed in the left superior longitudinal fasciculus (SLF_L) region (1.190 vs. 0.190, p < 0.001). In the two-sample t-test analysis of white matter ReHo, stroke patients exhibited a decrease in ReHo values in the GCC and BCC regions (GCC: 0.859 vs. 1.375; BCC: 1.156 vs. 1.687, p < 0.001), indicating values lower than those in the healthy control group. Using leave-one-out cross-validation (LOOCV) to evaluate the white matter DC and ReHo feature values through SVM classification models for stroke patients and healthy controls, the DC classification AUC was 0.89, and the ReHo classification AUC reached 0.98. These results suggest that the features possess validity and discriminative power. These findings suggest alterations in functional connectivity in specific white matter regions following stroke. Specifically, we observed a weakening of functional connectivity in the genu of the corpus callosum (GCC), the body of the corpus callosum (BCC), and the left anterior corona radiata (ACR_L) regions, while compensatory functional connectivity was enhanced in the left superior longitudinal fasciculus (SLF_L) region. These findings reveal the reorganization characteristics of white matter functional networks after stroke, which may provide potential biomarkers for the rehabilitation treatment of stroke patients and offer new clinical insights for their rehabilitation and treatment.